Abstract
The small animal PET is an innovative preclinical imaging technique that is meant to visualise biological processes of tissues in a living organism. The most important characteristic is the very high spatial resolution that makes those tomographs suitable for imaging small animals like mice. The employment of different radiolabelled compounds allows to highlight the overexpression or nonexpression of many metabolic pathways, helping to profile in vivo the cancer from a biological point of view, to predict or measure the response to experimental therapies, to observe the metabolic modification of the cancer over time, and to test new labelled compound to be eventually used for clinical PET. Main drawback is the very high cost of the scanners and the need of a radiopharmacy, partly cyclotron based, to synthesise as many PET tracers as possible.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Apisarnthanarax S, Alauddin MM, Mourtada F, Ariga H, Raju U, Mawlawi O, Han D, Bornmann WG, Ajani JA, Milas L, Gelovani JG, Chao KS (2006) Early detection of chemoradioresponse in esophageal carcinoma by 3-deoxy-3-3H-fluorothymidine using preclinical tumor models. Clin Cancer Res 12:4590–4597
Bauwens M, De Saint-Hubert M, Devos E, Deckers N, Reutelingsperger C, Mortelmans L, Himmelreich U, Mottaghy FM, Verbruggen A (2011) Site-specific 68Ga-labeled annexin A5 as a PET imaging agent for apoptosis. Nucl Med Biol 38:381–392
Cai W, Chen K, Mohamedali KA, Cao Q, Gambhir SS, Rosenblu MG, Chen X (2006) PET of vascular endothelial growth factor receptor expression. J Nucl Med 47:2048–2056
Cauchon N, Langlois R, Rousseau JA, Tessier G, Cadorette J, Lecomte R, Hunting DJ, Pavan RA, Zeisler SK, van Lier JE (2007) PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging 34:247–258
Cheng C, Pan L, Dimitrakopoulou-Strauss A, Schafer M, Wangler C, Wangler B, Haberkorn U, Strauss LG (2011) Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line. EJNMMI Res 1:34
Cherry SR (2006) The 2006 Henry N. Wagner lecture: of mice and men (and Positrons)—advances in PET imaging technology. J Nucl Med 47:1735–1745
Dobrucki LW, Sinusas AJ (2005) Molecular imaging: a new approach to nuclear cardiology. Q J Nucl Med Mol Imaging 49:106–115
Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA (2006) Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 47:999–1006
Hoekstra CJ, Paglianiti I, Hoekstra OS, Smit EF, Postmus PE, Teule GJJ, Lammertsma AA (2000) Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med 27:731–743
Hsueh WA, Kesner AL, Gangloff A, Pegram MD, Beryt M, Czernin J, Phelps ME, Silverman DHS (2006) Predicting chemotherapy response to paclitaxel with 18F-fluoropaclitaxel and PET. J Nucl Med 47:1995–1999
Lewisa JS, Achilefub S, Garbowc JR, Laforesta R, Welch MJ (2002) Small animal imaging: current technology and perspectives for oncological imaging. Eur J Cancer 38:2173–2188
Liu S (2006) Radiolabeled multimeric cyclic RGD peptides as integrin αvβ3 targeted radiotracers for tumor imaging. Mol Pharm 3:472–487
Myers R, Hume S (2002) Small animal PET. Eur Neuropsychopharmacol 12:545–555
Nanni C, Di Leo K, Tonelli R, Pettinato C, Rubello D, Spinelli A, Trespidi S, Ambrosini V, Castellucci P, Farsad M, Franchi R, Pession A, Fanti S (2007) FDG small animal PET permits early detection of malignant cells in a xenograft murine model. Eur J Nucl Med Mol Imaging 34:755–762
Sherif HM, Saraste A, Nekolla SG, Weidl E, Reder S, Tapfer A, Rudelius M, Higuchi T, Botnar RM, Wester HJ, Schwaiger M (2012) Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats. J Nucl Med 53:318–323
Sossi V, Ruth TJ (2005) Micropet imaging: in vivo biochemistry in small animals. J Neural Transm 112:319–330
Su H, Bodenstein C, Dumont RA, Seimbille Y, Dubinett S, Phelps ME, Herschman H, Czernin J, Weber W (2006) Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 12:5659–5667
Yaghoubi SS, Couto MA, Chen CC, Polavaram L, Cui G, Sen L, Gambhir SS (2006) Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk’s expression. J Nucl Med 47:706–715
Wang Y, Seidel J, Tsui BM, Vaquero JJ, Pomper MG (2006) Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner. J Nucl Med 47:1891–1900
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nanni, C., Fanti, S. (2013). Applications of Small Animal PET. In: Schober, O., Riemann, B. (eds) Molecular Imaging in Oncology. Recent Results in Cancer Research, vol 187. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-10853-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-10853-2_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-10852-5
Online ISBN: 978-3-642-10853-2
eBook Packages: MedicineMedicine (R0)